JD III - Trulieve Cannabis Chief Sec
| TCNNF Stock | USD 6.03 0.10 1.63% |
Insider
JD III is Chief Sec of Trulieve Cannabis Corp
| Age | 54 |
| Phone | 850 480 7955 |
| Web | https://www.trulieve.com |
Trulieve Cannabis Management Efficiency
The company has return on total asset (ROA) of 0.0479 % which means that it generated a profit of $0.0479 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1421) %, meaning that it generated substantial loss on money invested by shareholders. Trulieve Cannabis' management efficiency ratios could be used to measure how well Trulieve Cannabis manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Sunday Hoy | Tactile Systems Technology | N/A | |
| Yiftach Roth | Brainsway | 53 | |
| Eyal Shamir | Icecure Medical | 63 | |
| Darrell Rigel | STRATA Skin Sciences | 73 | |
| Robert Moccia | STRATA Skin Sciences | 65 | |
| Nikolai Kabelev | STRATA Skin Sciences | 48 | |
| Rajiv Silva | Venus Concept | 57 | |
| Keith Simeone | STRATA Skin Sciences | N/A | |
| Richard Ginn | Tenon Medical | 58 | |
| Christopher Lesovitz | STRATA Skin Sciences | 41 | |
| Jonathan Paris | Rapid Micro Biosystems | 48 | |
| Moria Ankri | Brainsway | 40 | |
| Avner Hagai | Brainsway | 68 | |
| Ronen CPA | Icecure Medical | 55 | |
| Naum Muchnik | Icecure Medical | 48 | |
| William MBA | STRATA Skin Sciences | 58 | |
| Aron Tendler | Brainsway | N/A | |
| Jennifer Ernst | Tivic Health Systems | 56 | |
| Shay Levav | Icecure Medical | 47 | |
| MD ODonnell | Tactile Systems Technology | N/A | |
| Pr Zangen | Brainsway | 54 | |
Management Performance
| Return On Equity | -0.14 | |||
| Return On Asset | 0.0479 |
Trulieve Cannabis Corp Leadership Team
Elected by the shareholders, the Trulieve Cannabis' board of directors comprises two types of representatives: Trulieve Cannabis inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Trulieve. The board's role is to monitor Trulieve Cannabis' management team and ensure that shareholders' interests are well served. Trulieve Cannabis' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Trulieve Cannabis' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kimberly Rivers, Chairman Founder | ||
| Rebecca Young, VP Officer | ||
| Alex CPA, Chief Officer | ||
| Robert Kremer, Exec Communications | ||
| JD III, Chief Sec | ||
| Jason Pernell, Chief Officer | ||
| Victoria Walker, Director Relations | ||
| Nilyum Jhala, Chief Officer | ||
| Christine Hersey, Director Relations | ||
| Steven White, President |
Trulieve Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Trulieve Cannabis a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.14 | |||
| Return On Asset | 0.0479 | |||
| Profit Margin | (0.19) % | |||
| Operating Margin | 0.14 % | |||
| Current Valuation | 2.48 B | |||
| Shares Outstanding | 159.64 M | |||
| Shares Owned By Insiders | 8.76 % | |||
| Shares Owned By Institutions | 12.51 % | |||
| Price To Earning | 23.96 X | |||
| Price To Book | 0.83 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Trulieve OTC Stock
Trulieve Cannabis financial ratios help investors to determine whether Trulieve OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Trulieve with respect to the benefits of owning Trulieve Cannabis security.